Avoid common mistakes on your manuscript.
Background
Dietary intake alters specifically human gut microbiota and mucosal immune response. Inflammation is major initiating factor of metabolic associated diseases namely CVD, obesity and diabetes type II.
The aim
was to provide the scientific background for the implementation of personalised diets for the prevention and treatment of metabolic associated diseases.
Materials and methods
Classic and modern experimental systems, animal and cells models in preclinical investigation had been used. Methanolic extracts of edible plants: nettle, dill, kale, persimmon, pomegranate, and Sideritis scardica were administered to mice orally for two weeks (15 mg/200µl/day/mouse). Level of IgAs in gut contents and cytokine profiles in supernatants of fragment cultures of gut associated lymphoid tissues was measured by ELISA, and numbers of immune cells quantified by FACS. Human DCs derived from peripheral blood monocytes were exposed to plant extracts at 2 mg/ml for 6 and 24 hours. The expression of CD markers by DCs and levels of secreted cytokines were assessed before and after exposure to the extracts. Clinical trials had been performed in order to detect the early microbial and immunological biomarkers and efficacy of polyphenols reach extracts effect on CVD functions.
Results
Edible plants induced a shift in expression of pro-/anti-inflammatory CD1a molecules on a surface of human DCs derived from peripheral blood monocytes. Commensal bacteria act on moDCs differentiation and activation by dose- and strain-specific manner, altering the expression of CD1a, NOD-2, RLH, PPARγ and RARα genes and cytokines production. Plant extracts and commensal microorganisms modulate the humoral and cellular mucosal immune response in GALT tissues on mice models differently regulating IgA secretion by peritoneal cavity B1/B2 cells and compartment of small intestine. Microbiological and immunological biomarkers of metabolic associated diseases as a result of evaluation of all the complexity diagnostic parameters had been found. Selected plants were able affect endothelial function, lipid profile and insulin sensitivity of patients with metabolic and cardiovascular diseases in randomised controlled trial.
Conclusion
These results support the concept of potential implementation of personalised diets for the patients with metabolic associated diseases.
Outlook and expert recommendations
The current challenge is to perform clinical intervention study according to EFSA demands and to criteria of evidence-based medicine to investigate efficacy of personalised diets developed from components and original recipes of traditional foods.
Acknowledgments
The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227118.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Petrov, V.O., Chendey, T.V. & Boyko, N.V. Personalized diets in prevention and treatment of metabolic associated diseases. EPMA Journal 5 (Suppl 1), A138 (2014). https://doi.org/10.1186/1878-5085-5-S1-A138
Published:
DOI: https://doi.org/10.1186/1878-5085-5-S1-A138